eyenovia-logo 3

Investor Relations

Investor Relations

Corporate Profile

Our Vision is to Improve Yours. Eyenovia is a public eye care company with topical ophthalmic therapies that are easier to use and easier to live with. The Optejet® is the only FDA-approved ophthalmic spray alternative to eye drops.

Presentation & Investor Materials

Price

Change
 
Volume

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Recent News Releases
09/05/24
Eyenovia Announces Taiwan Export License Approval to Commence Shipment of Clobetasol Propionate Ophthalmic Suspension (0.05%) to the U.S.
Read More
09/03/24
Eyenovia Announces Appointment of Experienced Finance and Accounting Executive Andrew Jones as Chief Financial Officer
Read More
08/23/24
Eyenovia Announces Closing of Public Offering
Read More
Upcoming Events
There are currently no events scheduled.
Copyright © Eyenovia, Inc. All rights reserved.